Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined active and passive immunization in non-responders to prior hepatitis B vaccination
2007-001744-53Phase 2Terminated
- Sponsor
- Leipzig University
- Start
- Feb 2008
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in hepatitis B (HBV) comparing HBVAXPRO + Hepatect with HBVAXPRO alone (2 arms). Primary endpoint: Protective anti-HBs antibody titer achievement. Started Feb 2008; status: terminated.
02
Drugs
Recombivax HBhepatitis B immune globulin
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2007-001744-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001744-53.